Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis.

It may be significant that patients in the UK with neuroblastomas tend to be diagnosed at an older age and with higher stage disease than in other European countries and the USA (Powell et al, 1998) and might therefore be expected to show a poorer outcome.

also in 13,097 other papers